Immune checkpoint inhibition for pancreatic ductal adenocarcinoma: limitations and prospects: a systematic review

par Hong-Bo Li, Zi-Han Yang, Qing-Qu Guo
Publié 2021

Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location

par Min Kyu Sung, Yejong Park, Bong Jun Kwak, Eunsung Jun, Woohyung Lee, Ki Byung Song, Jae Hoon Lee, Dae Wook Hwang, Song Cheol Kim
Publié 2021

Chloroquine Potentiates the Anticancer Effect of Pterostilbene on Pancreatic Cancer by Inhibiting Autophagy and Downregulating the RAGE/STAT3 Pathway

par Rong-Jane Chen, Yi-Jhen Lyu, Yu-Ying Chen, Yen-Chien Lee, Min-Hsiung Pan, Yuan-Soon Ho, Ying-Jan Wang
Publié 2021

CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid‐derived suppressor cells

par Haitao Gu, Wensheng Deng, Zhong Zheng, Ke Wu, Feng Sun
Publié 2021

Identification of Hub Genes in Pancreatic Ductal Adenocarci-noma Using Bioinformatics Analysis

par Congcong Wang, Jianping Guo, Xiaoyang Zhao, Jia Jia, Wenting Xu, Peng Wan, Changgang Sun
Publié 2021

Hyaluronic Acid Conjugated Metformin-Phospholipid Sonocomplex: A Biphasic Complexation Approach to Correct Hypoxic Tumour Microenvironment

par Farag MM, Abd El Malak NS, Yehia SA, Ahmed MA
Publié 2021

Cell Lineage Infidelity in PDAC Progression and Therapy Resistance

par Antonia Malinova, Lisa Veghini, Francisco X. Real, Francisco X. Real, Francisco X. Real, Vincenzo Corbo, Vincenzo Corbo
Publié 2021

Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma: Role of the Radiologist and Oncologist in the Era of Precision Medicine

par Federica Vernuccio, Carlo Messina, Valeria Merz, Roberto Cannella, Massimo Midiri
Publié 2021

Radiation combines with immune checkpoint blockade to enhance T cell priming in a murine model of poorly immunogenic pancreatic cancer

par Courtney T. Stump, Kevin Roehle, Nataly Manjarrez Orduno, Stephanie K. Dougan
Publié 2021

Blood small extracellular vesicles derived miRNAs to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis

par Shiwei Guo, Hao Qin, Ke Liu, Huan Wang, Sijia Bai, Shiyi Liu, Zhuo Shao, Yanan Zhang, Bin Song, Xiaoya Xu, Jing Shen, Peng Zeng, Xiaohan Shi, Hao Chen, Suizhi Gao, Jiajia Xu, Yaqi Pan, Lei Xiong, Fugen Li, Dadong Zhang, Xiaodong Jiao, Gang Jin
Publié 2021

Potential Prognostic Biomarkers of OSBPL Family Genes in Patients with Pancreatic Ductal Adenocarcinoma

par Cheng-Wei Chou, Yu-Hsiu Hsieh, Su-Chi Ku, Wan-Jou Shen, Gangga Anuraga, Hoang Dang Khoa Ta, Kuen-Haur Lee, Yu-Cheng Lee, Cheng-Hsien Lin, Chih-Yang Wang, Wei-Jan Wang
Publié 2021

Targeting Tumor-Stromal Interactions in Pancreatic Cancer: Impact of Collagens and Mechanical Traits

par Parniyan Maneshi, Parniyan Maneshi, James Mason, James Mason, Mitesh Dongre, Mitesh Dongre, Daniel Öhlund, Daniel Öhlund
Publié 2021

Nanomedicine Strategies to Enhance Tumor Drug Penetration in Pancreatic Cancer

par Lu T, Prakash J
Publié 2021

High expression of WNT7A predicts poor prognosis and promote tumor metastasis in pancreatic ductal adenocarcinoma

par Dong-jin Wu, Yong-sheng Jiang, Rui-zhe He, Ling-ye Tao, Min-wei Yang, Xue-liang Fu, Jiang-yu Yang, Kun Zhu
Publié 2018

OXCT1 Enhances Gemcitabine Resistance Through NF-κB Pathway in Pancreatic Ductal Adenocarcinoma

par Jinsheng Ding, Jinsheng Ding, Jinsheng Ding, Hui Li, Hui Li, Yang Liu, Yang Liu, Yongjie Xie, Yongjie Xie, Jie Yu, Huizhi Sun, Huizhi Sun, Di Xiao, Yizhang Zhou, Li Bao, Hongwei Wang, Chuntao Gao
Publié 2021

Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples

par Emmy Borgmästars, Erik Lundberg, Daniel Öhlund, Hanna Nyström, Oskar Franklin, Christina Lundin, Pär Jonsson, Malin Sund
Publié 2021

Discovery of GOT1 Inhibitors from a Marine-Derived <i>Aspergillus terreus</i> That Act against Pancreatic Ductal Adenocarcinoma

par Shan Yan, Changxing Qi, Wei Song, Qianqian Xu, Lianghu Gu, Weiguang Sun, Yonghui Zhang
Publié 2021

ATG4B Inhibitor UAMC-2526 Potentiates the Chemotherapeutic Effect of Gemcitabine in a Panc02 Mouse Model of Pancreatic Ductal Adenocarcinoma

par Farnaz Sedigheh Takhsha, Christel Vangestel, Christel Vangestel, Muhammet Tanc, Muhammet Tanc, Sven De Bruycker, Sven De Bruycker, Maya Berg, Isabel Pintelon, Sigrid Stroobants, Sigrid Stroobants, Guido R. Y. De Meyer, Guido R. Y. De Meyer, Pieter Van Der Veken, Pieter Van Der Veken, Wim Martinet, Wim Martinet
Publié 2021

Deciphering CHFR Role in Pancreatic Ductal Adenocarcinoma

par Iranzu González-Borja, Emilia Alors-Pérez, Emilia Alors-Pérez, Emilia Alors-Pérez, Emilia Alors-Pérez, Irene Amat, Laura Alonso, Cristina Viyuela-García, Cristina Viyuela-García, Cristina Viyuela-García, Saioa Goñi, José C. Reyes, María Ceballos-Chávez, Irene Hernández-García, Marina E. Sánchez-Frías, Marina E. Sánchez-Frías, Marina E. Sánchez-Frías, Enrique Santamaría, Socorro Razquin, Álvaro Arjona-Sánchez, Álvaro Arjona-Sánchez, Álvaro Arjona-Sánchez, Virginia Arrazubi, Jairo Pérez-Sanz, Ruth Vera, Joaquín Fernández-Irigoyen, Justo P. Castaño, Justo P. Castaño, Justo P. Castaño, Justo P. Castaño, Antonio Viúdez, Antonio Viúdez, Antonio Viúdez
Publié 2021

Advances in Pancreatic Ductal Adenocarcinoma Treatment

par Eric M. Anderson, Shant Thomassian, Jun Gong, Andrew Hendifar, Arsen Osipov
Publié 2021